FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江西一脈陽光集團股份有限公司 | 2. 股份分類 | 普通股 | 股份類別 | 其他類別 (請註明) | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | - | 說明 | 未上市股份 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 106,933,758 RMB | | | 1 RMB | | 106,933,758 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 106,933,758 RMB | | | 1 RMB | | 106,933,758 | 本月底法定/註冊股本總額： RMB 401,061,832 第 1 頁 共 10 頁 v ...

Core Viewpoint - The company has entered into a strategic framework cooperation agreement with the People's Government of Qingyang City, Gansu Province, and its incubated medical imaging AI company, Shanghai Yinghe Yimai Intelligent Technology Co., Ltd. This collaboration aims to enhance regional medical resource integration and governance capabilities, particularly in the northwest region of China [1] Group 1 - The strategic cooperation will focus on building a shared medical imaging center, an interconnected cloud indexing platform, and a trusted health data space [1] - The initiative aims to effectively integrate medical resources and provide standardized, high-quality medical imaging services to local healthcare institutions [1] - The collaboration will promote the construction of a medical information platform, addressing issues such as data silos and redundant examinations, thereby improving resource utilization efficiency [1] Group 2 - The board believes that this strategic cooperation will help expand the company's market presence in the northwest region and enhance the footprint of medical imaging sharing centers [1] - The agreement aligns with the overall interests of the company and its shareholders [1]

Core Viewpoint - The company has entered into a strategic framework cooperation agreement with the People's Government of Qingyang City, Gansu Province, and its incubated medical imaging AI company, Shanghai Yinghe Medical Technology Co., Ltd. This collaboration aims to establish a shared medical imaging center and a healthcare data space, enhancing regional medical resource integration and efficiency [1]. Group 1 - The strategic cooperation will focus on building a regional shared imaging diagnostic center and a digital platform to effectively integrate medical resources [1]. - The initiative aims to provide standardized and high-quality medical imaging services to local medical institutions [1]. - The collaboration will promote the construction of a medical information platform, addressing issues such as data silos and redundant examinations, thereby improving resource utilization efficiency [1]. Group 2 - The board believes that this strategic cooperation will enhance the company's ability to integrate and govern regional medical resources [1]. - The partnership is expected to expand the company's market presence in the northwest region of China [1]. - The initiative aligns with the overall interests of the company and its shareholders by broadening the footprint of shared medical imaging centers [1].

Core Viewpoint - The company has entered into a strategic framework cooperation agreement with the People's Government of Qingyang City, Gansu Province, and its incubated medical imaging AI company, Shanghai Yinghe Yimai Intelligent Technology Co., Ltd. This collaboration aims to enhance regional medical resource integration and governance capabilities, particularly in the northwest region of China [1] Group 1 - The strategic cooperation will focus on building a shared medical imaging center, an interconnected cloud indexing platform, and a trusted healthcare data space [1] - The initiative aims to effectively integrate medical resources and provide standardized, high-quality medical imaging services to local healthcare institutions [1] - The collaboration will promote the construction of a medical information platform, addressing issues such as data silos and redundant examinations, thereby improving resource utilization efficiency [1] Group 2 - The board believes that this strategic cooperation will help expand the company's market presence in the northwest region and enhance the footprint of the medical imaging sharing center [1] - The agreement aligns with the overall interests of the company and its shareholders [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容所產生或因依 賴該等內容而引致的任何損失承擔任何責任。 Jiangxi Rimag Group Co., Ltd. 江西一脈陽光集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2522) 自願公告 與慶陽市政府及影禾醫脈訂立戰略框架合作協議 本公告由江西一脈陽光集團股份有限公司（「本公司」，連同其附屬公司統稱「本集 團」）董事（「董事」）會（「董事會」）自願作出，以知會本公司股東及潛在投資者本 集團最新的業務發展狀況。 董事會欣然宣佈，本公司近日與甘肅省慶陽市人民政府（「慶陽市政府」）以及本公 司孵化的醫學影像人工智能公司上海影禾醫脈智能科技有限公司（「影禾醫脈」）訂 立戰略框架合作協議。根據該戰略框架合作協議，三方擬就建設共享醫學影像中 心、影響雲索引互聯互通互認平台和醫療健康可信數據空間開展戰略合作（「戰略 合作」）。戰略合作將通過建設區域共享型影像診斷中心與數字化平台，有效整合 醫療資源，為當地醫療機構提供標準化、高質量的醫學 ...

智通财经APP讯，一脉阳光(02522)发布公告，该公司于2025年11月24日斥资51.72万港元回购3.45万股股 份，每股回购价格为14.86-15.06港元。 （原标题：一脉阳光(02522)11月24日斥资51.72万港元回购3.45万股） ...

一脉阳光(02522)发布公告，该公司于2025年11月24日斥资51.72万港元回购3.45万股股份，每股回购价 格为14.86-15.06港元。 ...

格隆汇11月24日丨一脉阳光(02522.HK)公告，11月24日耗资51.7万港元回购3.5万股。 ...

呈交日期： 2025年11月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02522 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | ...

Group 1 - The core point of the article is that southbound funds have increased their holdings in Yipai Sunshine (02522.HK), with a total net increase of 443.35 million shares over the last five trading days [1][2] - As of November 21, 2025, southbound funds hold 130 million shares of Yipai Sunshine, accounting for 44.32% of the company's total issued ordinary shares [1][2] - The increase in holdings has been observed on three out of the last five trading days, indicating a positive trend in investor sentiment towards the company [1][2] Group 2 - Yipai Sunshine Group Co., Ltd. is primarily engaged in specialized medical imaging services in China, providing imaging services and solutions [2] - The company operates three segments: imaging center services, imaging solutions, and Yipai cloud services, which support the development of imaging center services and data-driven operations [2]